NJL-11475-21632 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-21
Dose 1 — Pfizer-BioNTech
2022-07-23
Dose 2 — Pfizer-BioNTech
2022-07-27
Registered in v-safe
2022-07-27
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Oral herpes — Feeling: Good

Free text: Cold sore

MedDRA releases: 2024-11 · check-in free text available
2022-07-28
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-30
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-08
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-13
Survey response — day 21, dose 2, under 3
MedDRA: Office visit, Pyrexia, Rash — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Rash, followed by high fever, and possible hand foot and mouth disease · Healthcare visit (other): Pediatrician visit

MedDRA releases: 2024-11 · check-in free text available
2022-08-13
Report sent to call center — day 21, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-08-15
Call 1 — Left Voicemail
2022-08-15
Call successful
Does not wish to fill out VAERS report
2022-08-20
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-29
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-03
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-21
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-21	Pfizer-BioNTech	No
2	2022-07-23	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-27

Systemic reaction (other): Cold sore

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-13

Symptoms: Rash, followed by high fever, and possible hand foot and mouth disease

Healthcare visit (other): Pediatrician visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rash	·	·	✓
SRO	Oral herpes	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release